Regulatory
IND (Investigational New Drug)
An FDA application that must be approved before human clinical trials can begin in the US. The IND includes preclinical data, manufacturing information, and clinical protocols.
See How IND (Investigational New Drug) Affects Deal Economics
Model deal terms with real benchmark data from 3,000+ biopharma transactions.